CYCC
Price
$0.25
Change
-$0.05 (-16.67%)
Updated
May 9 closing price
Capitalization
840.62M
UNCY
Price
$0.55
Change
-$0.07 (-11.29%)
Updated
May 9 closing price
Capitalization
66.35M
9 days until earnings call
Ad is loading...

CYCC vs UNCY

Header iconCYCC vs UNCY Comparison
Open Charts CYCC vs UNCYBanner chart's image
Cyclacel Pharmaceuticals
Price$0.25
Change-$0.05 (-16.67%)
Volume$1.26M
Capitalization840.62M
Unicycive Therapeutics
Price$0.55
Change-$0.07 (-11.29%)
Volume$1.8M
Capitalization66.35M
CYCC vs UNCY Comparison Chart
Loading...
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCC vs. UNCY commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCC is a StrongBuy and UNCY is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (CYCC: $0.25 vs. UNCY: $0.55)
Brand notoriety: CYCC and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCC: 39% vs. UNCY: 209%
Market capitalization -- CYCC: $840.62M vs. UNCY: $66.35M
CYCC [@Biotechnology] is valued at $840.62M. UNCY’s [@Biotechnology] market capitalization is $66.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCC’s FA Score shows that 1 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • CYCC’s FA Score: 1 green, 4 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, CYCC is a better buy in the long-term than UNCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCC’s TA Score shows that 5 TA indicator(s) are bullish while UNCY’s TA Score has 5 bullish TA indicator(s).

  • CYCC’s TA Score: 5 bullish, 5 bearish.
  • UNCY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CYCC and UNCY are a good buy in the short-term.

Price Growth

CYCC (@Biotechnology) experienced а +0.88% price change this week, while UNCY (@Biotechnology) price change was -15.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

CYCC is expected to report earnings on Apr 02, 2025.

UNCY is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYCC($841M) has a higher market cap than UNCY($66.3M). UNCY YTD gains are higher at: -30.748 vs. CYCC (-32.606). CYCC has higher annual earnings (EBITDA): -15.47M vs. UNCY (-22.56M). UNCY has more cash in the bank: 32.3M vs. CYCC (2.98M). CYCC has less debt than UNCY: CYCC (0) vs UNCY (807K). CYCC has higher revenues than UNCY: CYCC (74K) vs UNCY (0).
CYCCUNCYCYCC / UNCY
Capitalization841M66.3M1,268%
EBITDA-15.47M-22.56M69%
Gain YTD-32.606-30.748106%
P/E RatioN/AN/A-
Revenue74K0-
Total Cash2.98M32.3M9%
Total Debt0807K-
FUNDAMENTALS RATINGS
CYCC: Fundamental Ratings
CYCC
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYCCUNCY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 18 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEE70.311.99
+2.91%
Nextera Energy Inc
PRO16.910.04
+0.24%
Pros Holdings
COLD17.12-0.22
-1.27%
Americold Realty Trust
PGEN1.33-0.02
-1.48%
Precigen
GANX1.94-0.09
-4.20%
Gain Therapeutics

CYCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYCC has been loosely correlated with CKPT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CYCC jumps, then CKPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCC
1D Price
Change %
CYCC100%
-15.53%
CKPT - CYCC
52%
Loosely correlated
+0.72%
MIRM - CYCC
36%
Loosely correlated
-2.14%
ORMP - CYCC
30%
Poorly correlated
-1.75%
IMMP - CYCC
27%
Poorly correlated
-0.54%
RNAC - CYCC
26%
Poorly correlated
-4.99%
More